The estimated Net Worth of Jason M. Hollar is at least $34.5 Million dollars as of 15 August 2024. Mr. Hollar owns over 73,171 units of Cardinal Health stock worth over $22,402,041 and over the last 7 years he sold CAH stock worth over $7,973,444. In addition, he makes $4,104,250 as Chief Financial Officer at Cardinal Health.
Sign up
Mr. Hollar CAH stock SEC Form 4 insiders trading
Jason has made over 6 trades of the Cardinal Health stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 73,171 units of CAH stock worth $7,973,444 on 15 August 2024.
The largest trade he's ever made was selling 73,171 units of Cardinal Health stock on 15 August 2024 worth over $7,973,444. On average, Jason trades about 4,731 units every 65 days since 2017. As of 15 August 2024 he still owns at least 197,636 units of Cardinal Health stock.
You can see the complete history of Mr. Hollar stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jason Hollar biography
Jason M. Hollar serves as Chief Financial Officer of the Company. Mr. Hollar has been Executive Vice President and CFO of Tenneco Inc. ("Tenneco"), a company that designs, manufactures, markets and sells products and services for light vehicle, commercial truck, off-highway, industrial and after-market customers, since July 2018. He joined Tenneco as Senior Vice President Finance and served in that role from June 2017 to June 2018.
What is the salary of Jason Hollar?
As the Chief Financial Officer of Cardinal Health, the total compensation of Jason Hollar at Cardinal Health is $4,104,250. There are 2 executives at Cardinal Health getting paid more, with Michael Kaufmann having the highest compensation of $14,217,100.
How old is Jason Hollar?
Jason Hollar is 46, he's been the Chief Financial Officer of Cardinal Health since 2020. There are 25 older and 1 younger executives at Cardinal Health. The oldest executive at Cardinal Health, Inc. is John Losh, 74, who is the Independent Director.
What's Jason Hollar's mailing address?
Jason's mailing address filed with the SEC is 7000, Cardinal Place, Dublin, Washington Township, Franklin County, Ohio, 43017, United States.
Insiders trading at Cardinal Health
Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett, and Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.
What does Cardinal Health do?
cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.
What does Cardinal Health's logo look like?
Complete history of Mr. Hollar stock trades at Cardinal Health, DaVita Inc, and Tsakos Navigation
Cardinal Health executives and stock owners
Cardinal Health executives and other stock owners filed with the SEC include:
-
Michael Kaufmann,
Chief Executive Officer, Director -
Victor Crawford,
Chief Executive Officer - Pharmaceutical Segment -
Jason Hollar,
Chief Financial Officer -
Stephen Mason,
Chief Executive Officer - Medical Segment -
Jessica Mayer,
Chief Legal and Compliance Officer -
Michael C. Kaufmann,
CEO & Director -
David Evans,
Independent Director -
Victor L. Crawford,
Chief Exec. Officer of Pharmaceutical Segment -
Jason M. Hollar,
Chief Financial Officer -
Stephen M. Mason,
Chief Exec. Officer of Medical Segment -
Jessica L. Mayer,
Chief Legal & Compliance Officer -
Gregory Kenny,
Independent Non-Executive Chairman of the Board -
Carrie Cox,
Independent Director -
John Losh,
Independent Director -
Bruce Downey,
Independent Director -
Dean Scarborough,
Independent Director -
Patricia Hemingway Hall,
Independent Director -
John Weiland,
Independent Director -
Calvin Darden,
Independent Director -
Nancy Killefer,
Independent Director -
Akhil Johri,
Independent Director -
Sheri Edison,
Independent Director -
Brian Rice,
Executive Vice President, Chief Information Officer and Customer Support Services -
Ola Snow,
Chief Human Resource Officer -
Dr. Michele A. M. Holcomb Ph.D.,
Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer -
Brian S. Rice,
Chief Information Officer, Exec. VP & Global Bus. Services -
Craig Cowman,
Exec. VP of Global Sourcing -
Kevin Moran,
VP of Investor Relations -
Patricia M. English,
Sr. VP & Chief Accounting Officer -
Pamela O. Kimmet,
Chief Human Resources Officer -
Michele Holcomb,
EVP - Strategy & Corp. Dev. -
Falk T Stephen,
EVP, Gen. Counsel & Corp. Sec. -
David P King,
Director -
Craig S Morford,
Chief Compliance Officer -
Colleen F. Arnold,
Director -
Stuart G Laws,
SVP & Chief Accounting Officer -
Donald M Jr. Casey,
CEO, Medical Segment -
Clayton M Jones,
Director -
David J Anderson,
Director -
Patricia Morrison,
Chief Information Officer -
Meghan Fitzgerald,
EVP, Strategy & Health Policy -
Carole S Watkins,
EVP - Human Resources -
Jon L Giacomin,
CEO, Medical Segment -
George S Barrett,
Chairman and CEO -
J Michael Losh,
Director -
Deborah Weitzman,
CEO, PSS Segment -
Jeffrey William Henderson,
Executive Vice President -
David W Raisbeck,
Director -
Michael A Lynch,
CEO, Medical Segment -
Glenn Britt,
Director -
Jean G Spaulding,
Director -
John F Finn,
Director -
Richard C Notebaert,
Director -
Mark R Blake,
EVP -- Strategy & Corp. Dev. -
James J Md Mongan,
Director -
Jorge M Gomez,
Chief Financial Officer -
Michael D Ohalleran,
Director -
Vivek Jain,
EVP - Corp Develop. & Strategy -
George H Conrades,
Director -
Ivan K Fong,
EVP, CLO & Secretary -
Robert D Walter,
Chairman and CEO -
David L Schlotterbeck,
Chmn & CEO-Clncl Techn & Svcs -
John B Mccoy,
Director -
Philip L Francis,
Director -
Matthew D Walter,
Director -
R Kerry Clark,
President and CEO -
Daniel J Walsh,
EVP, Chf Ethcs & Compl Offcr -
Mark W Parrish,
EVP; Group Pres.-Pharm. Distr. -
John F Havens,
Director -
David Bing,
Director -
Gary S Jensen,
SVP - Corporate Controller -
Robert L Gerbig,
Director -
Ronald K Labrum,
CEO-Healthcare Supply Chn Svc -
Brendan A Ford,
EVP - Corp. Development -
Anthony J Rucci,
EVP & Chief Admin. Officer -
Joseph C Papa,
Chmn & CEO, Pharm Techn & Svcs -
Stephen S Thomas,
EVP-Group Pres.-AIS -
Gary D Dolch,
EVP - Quality & Reg. Affairs -
George L Fotiades,
President & COO -
Eric Slusser,
SVP-Finance, CAO & Cntrllr -
Paul S Williams,
EVP, CLO & Secretary -
Jody R Davids,
EVP & CIO -
Richard J Miller,
EVP & CFO -
Aaron E Alt,
Chief Financial Officer -
Robert Azelby,
Director -
Patricia M English,
Chief Accounting Officer -
Christine Mundkur,
Director -
Steven Barg,
Director -
Michelle Brennan,
Director -
Michelle D. Greene,
Chief Information Officer -
Mary C. Scherer,
Chief Accounting Officer